Literature DB >> 22139694

Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants.

Ravi Sheshala1, Nurzalina Khan, Mallikarjun Chitneni, Yusrida Darwis.   

Abstract

The aim of this study was to formulate cost effective taste-masked orally disintegrating tablets of ondansetron, a bitter drug using different superdisintegrants by a wet granulation technique. Microcrystalline cellulose (Avicel) as a diluent and disintegrant in addition to aspartame as a sweetener were used in all formulations. The prepared tablets were evaluated for weight variation, thickness, hardness, friability, drug content, water content, in vitro disintegration time and in vitro drug release. The tablets' hardness was maintained in the range of 2-3 kg and friability was <1% for all batches. All tablet formulations disintegrated rapidly in vitro within 5.83 to 33.0 sec. The optimized formulation containing 15% Polyplasdone XL-10 released more than 90% of drug within 5 min and the release was comparable to that of a commercial product. In human volunteers, optimized formulation was found to have a pleasant taste and mouth feel and they disintegrated in the oral cavity within 12 sec. The stability results were also satisfactory. A pharmacokinetic study with the optimized formulation was performed in comparison with a reference (Zofer MD 8®) and they were found to be bioequivalent. In conclusion, a cost effective ondansetron orally disintegrating tablet was successfully prepared with acceptable hardness, desirable taste and rapid disintegration in the oral cavity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22139694     DOI: 10.1007/s12272-011-1115-y

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  7 in total

1.  Design and optimization of film-forming gel of etoricoxib using research surface methodology.

Authors:  Rabinarayan Parhi; V V Nishanth Goli
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

2.  Meloxicam taste-masked oral disintegrating tablet with dissolution enhanced by ion exchange resins and cyclodextrin.

Authors:  Wipada Samprasit; Prasert Akkaramongkolporn; Tanasait Ngawhirunpat; Theerasak Rojanarata; Praneet Opanasopit
Journal:  AAPS PharmSciTech       Date:  2013-07-09       Impact factor: 3.246

3.  The Disintegration Process in Microcrystalline Cellulose Based Tablets, Part 1: Influence of Temperature, Porosity and Superdisintegrants.

Authors:  Samy Yassin; Daniel J Goodwin; Andrew Anderson; Juraj Sibik; D Ian Wilson; Lynn F Gladden; J Axel Zeitler
Journal:  J Pharm Sci       Date:  2015-06-12       Impact factor: 3.534

Review 4.  A Review of Disintegration Mechanisms and Measurement Techniques.

Authors:  Daniel Markl; J Axel Zeitler
Journal:  Pharm Res       Date:  2017-03-01       Impact factor: 4.200

5.  Novel sublingual tablets of Atorvastatin calcium/Trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization.

Authors:  Noha N Atia; Hesham M Tawfeek; Azza H Rageh; Marwa R El-Zahry; Ahmed Abdelfattah; Mahmoud A Younis
Journal:  Saudi Pharm J       Date:  2019-02-05       Impact factor: 4.330

6.  Puzzle out Machine Learning Model-Explaining Disintegration Process in ODTs.

Authors:  Jakub Szlęk; Mohammad Hassan Khalid; Adam Pacławski; Natalia Czub; Aleksander Mendyk
Journal:  Pharmaceutics       Date:  2022-04-13       Impact factor: 6.525

7.  Selective Laser Sintering 3D Printing of Orally Disintegrating Printlets Containing Ondansetron.

Authors:  Nour Allahham; Fabrizio Fina; Carmen Marcuta; Lilia Kraschew; Wolfgang Mohr; Simon Gaisford; Abdul W Basit; Alvaro Goyanes
Journal:  Pharmaceutics       Date:  2020-01-30       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.